Document Detail

Inhaled nitric oxide for the treatment of preterm infants with respiratory distress syndrome.
MedLine Citation:
PMID:  18332638     Owner:  NLM     Status:  MEDLINE    
Many authors have hypothesized that inhaled nitric oxide (iNO) might acutely improve oxygenation in preterm neonates with infant respiratory distress syndrome (iRDS) and decrease the risk of bronchopulmonary dysplasia. The studies on the effects of iNO in preterm infants with iRDS have given contradictory results. We report their main methodological characteristics and the observed effects of iNO in preterm infants. Moreover, we discuss the infants' age at the beginning of the study, the dose and duration of iNO therapy, its potential effect on neurodevelopment, its relationship with surfactant properties, and the need to identify patients who are likely to respond to this therapy. We advise caution against the widespread use of iNO in preterm infants with iRDS. At present, it appears to be premature to have specific recommendations regarding the indications for iNO therapy in this group of patients. The conclusion of current trials and the follow-up studies of recently completed trials will give further data to guide neonatologists' decisions, and until then it is likely that clinicians will continue to make case-by-case decisions for the treatment of iNO in preterm infants with hypoxia that is unresponsive to other therapies. However, this decision should always be discussed with the parents.
Carlo Dani; Giovanna Bertini
Related Documents :
11150868 - Vaginal ultrasound as an adjunct to cervical digital examination in women at risk of ea...
11988028 - Nutritional assessment in preterm infants with special reference to body composition.
11209968 - The replacement of oestradiol and progesterone in very premature infants.
18758408 - Association between periodontitis in pregnancy and preterm or low birth weight: review ...
6128268 - Influence of maternal levels of blood glucose on fetal outcome.
3725498 - Neonatal polycythemia: frequency of clinical manifestations and other associated findings.
Publication Detail:
Type:  Journal Article     Date:  2008-03-07
Journal Detail:
Title:  Neonatology     Volume:  94     ISSN:  1661-7819     ISO Abbreviation:  -     Publication Date:  2008  
Date Detail:
Created Date:  2008-08-07     Completed Date:  2008-10-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101286577     Medline TA:  Neonatology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  87-95     Citation Subset:  IM    
Copyright Information:
(c) 2008 S. Karger AG, Basel
Division of Neonatology, Department of Surgical and Medical Critical Care, Careggi University Hospital, University of Florence School of Medicine, Florence, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Anoxia / etiology,  therapy
Clinical Trials as Topic
Infant, Newborn
Infant, Premature
Neonatology / methods*
Nitric Oxide / administration & dosage*,  contraindications
Respiratory Distress Syndrome, Newborn / complications,  therapy*
Treatment Outcome
Reg. No./Substance:
10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of serum high-molecular-weight and total adiponectin on arteriosclerosis in IgA nephropath...
Next Document:  Cord blood prolidase activity correlates with gestational age and birth weight.